Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Savitz Ryan
Over the trailing 90 days, Savitz Ryan (Other at Dianthus Therapeutics, Inc. /DE/) traded $3.8M of stock (net selling $2.5M) in DNTH, per 5 SEC Form 4 transactions.
- Role
- Other
- Companies
- DNTH
- Window
- Trailing 90 days · 5 transactions · CIK 1992324
- Net activity
- −$2.5M ($680K bought · $3.2M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 5 | $680K | $3.2M | −$2.5M |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-09 | DNTH | Sell | 10.4K | $1.0M | Open market or private sale |
| 2026-07-09 | DNTH | Sell | 31.2K | $0 | Exercise or conversion of derivative security |
| 2026-07-09 | DNTH | Buy | 31.2K | $680K | Exercise or conversion of derivative security |
| 2026-07-09 | DNTH | Sell | 5.6K | $568K | Open market or private sale |
| 2026-07-09 | DNTH | Sell | 15.3K | $1.6M | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Savitz's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.